Image via Wikipedia
I keep a close eye on the WIPO UDRP decisions, as sometimes they can be very interesting.
In most cases decisions are either upheld or denied and when they are upheld the normal followup would be for the domain in question to be transferred to the IP holder.
However WIPO’s latest set of UDRP decisions shows a different line of thought entirely.
In several cases involving pharmaceutical products the panel has decided in favour of cancelling the domains.
But what is to stop someone from simply re-registering them again? Couldn’t I or anyone else just grab the domains as soon as they became available for registration.
Maybe I’m missing some finer detail that only an “inner circle” is privy to.
